Javascript must be enabled to continue!
From ubiquitin‐proteasomal degradation to CDK1 inactivation: requirements for the first polar body extrusion in mouse oocytes
View through CrossRef
Completion of the first meiotic division, manifested by extrusion of the first polar body (PBI), depends on proteasomal degradation of cyclin B1 and securin and the subsequent respective CDK1 inactivation and chromosome segregation. We aimed at identifying the polyubiquitin signal that mediates proteasomal action and at a better characterization of the role of CDK1 inactivation at this stage of meiosis. Microinjections of mutated ubiquitin proteins into mouse oocytes revealed that interference with lysine‐11 polyubiquitin chains abrogated chromosome segregation and reduced PBI extrusion by 63% as compared to WT ubiquitin‐injected controls. Inactivation of CDK1 in oocytes arrested at first metaphase by a proteasome inhibitor fully rescued PBI extrusion. However, removal of CDK1 inhibition failed to allow progression to the second metaphase, rather, inducing PBI reengulfment in 62% of the oocytes. Inhibition of either PLK1 or MEK1/2 during the first anaphase changed spindle dimensions. The PLK1 inhibitor also blocked PBI emission and prevented RhoA translocation. Our results identified lysine‐11 rather than the canonic lysine‐48 ubiquitin chains as the degradation signal in oocytes resuming meiosis, further disclosing that CDK1 inactivation is necessary and sufficient for PBI emission. This information significantly contributes to our understanding of faulty chromosome segregation that may lead to aneuploidy.—Pomerantz, Y., Elbaz, J., Ben‐Eliezer, I., Reizel, Y., David, Y., Galiani, D., Nevo, N., Navon, A., Dekel, N. From ubiquitin‐proteasomal degradation to CDK1 inactivation: requirements for the first polar body extrusion in mouse oocytes.
FASEB J.
26, 4495–4505 (2012).
www.fasebj.org
Title: From ubiquitin‐proteasomal degradation to CDK1 inactivation: requirements for the first polar body extrusion in mouse oocytes
Description:
Completion of the first meiotic division, manifested by extrusion of the first polar body (PBI), depends on proteasomal degradation of cyclin B1 and securin and the subsequent respective CDK1 inactivation and chromosome segregation.
We aimed at identifying the polyubiquitin signal that mediates proteasomal action and at a better characterization of the role of CDK1 inactivation at this stage of meiosis.
Microinjections of mutated ubiquitin proteins into mouse oocytes revealed that interference with lysine‐11 polyubiquitin chains abrogated chromosome segregation and reduced PBI extrusion by 63% as compared to WT ubiquitin‐injected controls.
Inactivation of CDK1 in oocytes arrested at first metaphase by a proteasome inhibitor fully rescued PBI extrusion.
However, removal of CDK1 inhibition failed to allow progression to the second metaphase, rather, inducing PBI reengulfment in 62% of the oocytes.
Inhibition of either PLK1 or MEK1/2 during the first anaphase changed spindle dimensions.
The PLK1 inhibitor also blocked PBI emission and prevented RhoA translocation.
Our results identified lysine‐11 rather than the canonic lysine‐48 ubiquitin chains as the degradation signal in oocytes resuming meiosis, further disclosing that CDK1 inactivation is necessary and sufficient for PBI emission.
This information significantly contributes to our understanding of faulty chromosome segregation that may lead to aneuploidy.
—Pomerantz, Y.
, Elbaz, J.
, Ben‐Eliezer, I.
, Reizel, Y.
, David, Y.
, Galiani, D.
, Nevo, N.
, Navon, A.
, Dekel, N.
From ubiquitin‐proteasomal degradation to CDK1 inactivation: requirements for the first polar body extrusion in mouse oocytes.
FASEB J.
26, 4495–4505 (2012).
www.
fasebj.
org.
Related Results
O-105 Chromatin accessibility of oocytes contributes to PCOS transgenerational inheritance
O-105 Chromatin accessibility of oocytes contributes to PCOS transgenerational inheritance
Abstract
Study question
What is the underlying mechanism contributing to the transgenerational defects of oocytes and embryos of...
Tijelo u opusu Janka Polića Kamova
Tijelo u opusu Janka Polića Kamova
The doctoral disertation is dedicated to the concept of the body in the works of Janko Polić Kamov. The body is approached as a signifier system on the basis of which numerous and ...
Data from CDK1 Interacts with Sox2 and Promotes Tumor Initiation in Human Melanoma
Data from CDK1 Interacts with Sox2 and Promotes Tumor Initiation in Human Melanoma
<div>Abstract<p>Cancers are composed of heterogeneous subpopulations with various tumor-initiating capacities, yet key stem cell genes associated with enhanced tumor-in...
Data from CDK1 Interacts with Sox2 and Promotes Tumor Initiation in Human Melanoma
Data from CDK1 Interacts with Sox2 and Promotes Tumor Initiation in Human Melanoma
<div>Abstract<p>Cancers are composed of heterogeneous subpopulations with various tumor-initiating capacities, yet key stem cell genes associated with enhanced tumor-in...
Triad1 Regulates Myelopoiesis through Different Ubiquitin Ligase Activities.
Triad1 Regulates Myelopoiesis through Different Ubiquitin Ligase Activities.
Abstract
The modification of cellular proteins with poly-ubiquitin chains plays an essential role in hematopoiesis. Different types of ubiquitin chains may have oppo...
Ubiquitin and Ubiquitin‐like Protein Conjugation
Ubiquitin and Ubiquitin‐like Protein Conjugation
Abstract
Protein modification by ubiquitin and ubiquitin‐like proteins (Ubls) plays a pervasive role in eukaryotic cell regulation. One aim of this article is to survey t...
Influence of time delay on dynamics of cell cycle
Influence of time delay on dynamics of cell cycle
In this work, based on the Hill dynamics and Michaelis-Menten equation, a theoretical model is built to study the influence of time delay on the oscillation dynamics of a cyclin-de...
CDK1 as a Novel Potential Biomarker for Predicting the Prognosis of endometrioid ovarian carcinoma
CDK1 as a Novel Potential Biomarker for Predicting the Prognosis of endometrioid ovarian carcinoma
Objective:
Endometrioid ovarian carcinoma (EOC) is gynecological
malignancy. Prognostic classification of EOC remains challenging, and
the role of molecular marke...

